INOVIO expands global manufacturing consortium for its COVID-19 vaccine candidate

Vaccines |  News | 0 Comment | 04 Dec, 2020

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...Read more

EuBiologics partners with IVI for COVID-19 vaccine development

Vaccines |  News | 0 Comment | 04 Dec, 2020

The International Vaccine Institute (IVI) and South Korean company EuBiologics exchanged an MOU to cooperate in the clin...Read more

Experts elaborate on Asia's confidence and challenges with COVID-19 vaccine

Vaccines |  News | 0 Comment | 03 Dec, 2020

Vaccine confidence has never been more important, as the world waits for the first COVID-19 protection options to move t...Read more

Pfizer and BioNTech achieve world first authorization for COVID-19 vaccine

Vaccines |  News | 0 Comment | 02 Dec, 2020

Pfizer Inc. and BioNTech SE have announced that the Medicines & Healthcare Products Regulatory Agency (MHR...Read more

BioNTech-Pfizer apply CMA for COVID-19 Vaccine to the EMA

Vaccines |  News | 0 Comment | 02 Dec, 2020

BioNTech SE and Pfizer Inc. on 30 Nov 2020 have submitted a formal Application for Conditional Marketing ...Read more

Korea contributes $3M to CEPI to advance vaccine development

Vaccines |  News | 0 Comment | 30 Nov, 2020

The government of the Republic of Korea (ROK) has decided to contribute $3 million in 2020 for the first time to the Coa...Read more

AstraZeneca vaccine meet primary efficacy endpoint in preventing COVID-19

Vaccines |  News | 0 Comment | 27 Nov, 2020

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vacci...Read more

Korea inks MoU with Ecuador for global health R&D

Vaccines |  News | 0 Comment | 26 Nov, 2020

The International Vaccine Institute (IVI) and Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memo...Read more

Sputnik V vaccine single dose to be less than $10 at international markets

Vaccines |  News | 0 Comment | 25 Nov, 2020

The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a ...Read more

Korea pushes vaccine R&D for global health

Vaccines |  News | 1 Comment | 24 Nov, 2020

The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to j...Read more

Hester Biosciences Nepal unveils live thermo-tolerant PPR vaccine

Vaccines |  News | 0 Comment | 23 Nov, 2020

Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DD...Read more

CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains

Vaccines |  News | 0 Comment | 23 Nov, 2020

To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...Read more

Pfizer, BioNTech demonstrate 95% efficacy of COVID-19 vaccine

Vaccines |  News | 0 Comment | 23 Nov, 2020

Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...Read more

Cytiva supports Clover Biopharma to scale up output of COVID-19 vaccine candidate

Vaccines |  News | 0 Comment | 17 Nov, 2020

US-based Cytiva, a global life sciences leader, is supporting Shanghai-based Clover Biopharmaceuticals, a global clinica...Read more

Australia unveils plans for new flu vaccine facility

Vaccines |  News | 0 Comment | 16 Nov, 2020

The Australian government has announced that the largest flu vaccine manufacturing plant in the southern hemisphere will...Read more

South Korea to host production of 150M Sputnik V doses for global distribution

Vaccines |  News | 0 Comment | 13 Nov, 2020

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...Read more

Arcturus Therapeutics receives $220M from Singapore for COVID-19 vaccine development

Vaccines |  News | 0 Comment | 12 Nov, 2020

Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ong...Read more

COVID-19 vaccine candidate by Pfizer, BioNTech shows more than 90% effectivity

Vaccines |  News | 0 Comment | 10 Nov, 2020

Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...Read more